Placebo of the new presentation of 350 mg/sachet drug product (hereafter referred as vehicle) is a smooth clinical trials

A Phase 3, Multicentre, Randomised, Double-blind, Vehicle-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Tirbanibulin 10 mg/g Ointment Applied to a Treatment Field Larger Than 25 cm2 and up to 100 cm2 in Adult Patients With Actinic Keratosis

This study is testing a special ointment called Tirbanibulin for adults with a common sun-related skin condition called actinic keratosis on their face or scalp. It's looking at how well the ointment clears up the skin and if it's safe to use.